 Analgesics
|
|
Anesthetics
|
|
Anti-Addiction / Substance Abuse Treatment Agents
|
|
 Antibacterials
|
Aminoglycosides
|
Beta-lactam, Cephalosporins
|
Cephalosporin Antibacterials, 1st Generation
|
Cephalosporin Antibacterials, 2nd Generation
|
Cephalosporin Antibacterials, 3rd Generation
|
Cefdinir
|
Cefditoren
|
Cefixime
|
Cefotaxime
|
Cefpodoxime
|
Ceftazidime
|
Ceftibuten
|
Ceftriaxone
|
 D07659 Ceftriaxone (INN)
D00924 Ceftriaxone sodium hydrate (JP16); Ceftriaxone sodium (USP)
|
Cephalosporin Antibacterials, 4th Generation
|
Beta-lactam, Penicillins
|
Beta-lactam, Other
|
Macrolides
|
Quinolones
|
Sulfonamides
|
Tetracyclines
|
Antibacterials, Other
|
|
Anticonvulsants
|
|
Antidementia Agents
|
|
Antidepressants
|
|
Antiemetics
|
|
Antifungals
|
|
Antigout Agents
|
|
Anti-inflammatory Agents
|
|
Antimigraine Agents
|
|
Antimyasthenic Agents
|
|
Antimycobacterials
|
|
Antineoplastics
|
|
Antiparasitics
|
|
Antiparkinson Agents
|
|
Antipsychotics
|
|
Antispasticity Agents
|
|
Antivirals
|
|
Anxiolytics
|
|
Bipolar Agents
|
|
Blood Glucose Regulators
|
|
Blood Products / Modifiers / Volume Expanders
|
|
Cardiovascular Agents
|
|
Central Nervous System Agents
|
|
Dental and Oral Agents
|
|
Dermatological Agents
|
|
Enzyme Replacement / Modifying Agents
|
|
Gastrointestinal Agents
|
|
Genitourinary Agents
|
|
Hormonal Agents
|
|
Immunological Agents
|
|
Inflammatory Bowel Disease Agents
|
|
Metabolic Bone Disease Agents
|
|
Ophthalmic Agents
|
|
Otic Agents
|
|
Respiratory Tract Agents
|
|
Skeletal Muscle Relaxants
|
|
Sleep Disorder Agents
|
|
Therapeutic Nutrients / Minerals / Electrolytes
|
USP Drug Classification